Co-beneldopa (Benserazide/levodopa) Prescribing at KENSINGTON PARTNERSHIP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
100
Total Quantity
13.9K
NHS Cost
£870
vs National Avg
-33.8%
KENSINGTON PARTNERSHIP prescribed 100 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £870 to the NHS. This is 33.8% below the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
7
Jul 2026
5
Jul 2026
7
Jul 2026
8
Jul 2026
7
Jul 2026
9
Jul 2026
8
Jul 2026
11
Jul 2026
8
Jul 2026
10
Jul 2026
7
Jul 2026
13
Prescribing Details
| Total Items | 100 |
|---|---|
| Total Quantity | 13,900 |
| Total NHS Cost | £870 |
| Presentations | 7 different forms |
| vs National Average | -33.8% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 100 items |
|---|---|
| National average per practice | 151 items |
| Difference | -33.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.